Michael Hertl

Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus

Dédée F. Murrell, Sarah Dick, A. R. Ahmed et al. · Journal of the American Academy of Dermatology · 2008 · 575 citations · Full text

Pathogenesis, Immunology, Therapeutic Response +3

A Single Cycle of Rituximab for the Treatment of Severe Pemphigus

P. Joly, Hugo Mouquet, Jean‐Claude Roujeau et al. · New England Journal of Medicine · 2007 · 460 citations

Definitions and outcome measures for bullous pemphigoid: Recommendations by an international panel of experts

Dédée F. Murrell, Benjamin S. Daniel, P. Joly et al. · Journal of the American Academy of Dermatology · 2011 · 365 citations · Full text

Bullous Pemphigoid, Public Health, International Panel +3

Diagnosis and management of pemphigus: Recommendations of an international panel of experts

Dédée F. Murrell, S.M. Peña, P. Joly et al. · Journal of the American Academy of Dermatology · 2018 · 356 citations · Full text

Medicine, Dermatology, Pathology +1

Updated S2K guidelines on the management of pemphigus vulgaris and foliaceus initiated by the european academy of dermatology and venereology (EADV)

P. Joly, Barbara Horváth, Soner Uzun et al. · Journal of the European Academy of Dermatology and Venereology · 2020 · 319 citations · Full text